Clinical Benefit of Cardiac Resynchronization Therapy With a Defibrillator in Patients With an Ejection Fraction > 35% Estimated by Cardiac Magnetic Resonance

Cardiac resynchronization therapy with a defibrillator prolongs survival and improves quality of life in advanced heart failure. Traditionally, patients with ejection fraction > 35 estimated by echocardiography have been excluded. We assessed the prognostic impact of this therapy in a group of pa...

Full description

Bibliographic Details
Authors: Fabregat Andrés, Óscar, García-González, Pilar, Valle-Muñoz, Alfonso, Estornell-Erill, Jordi, Pérez-Boscá, Leandro, Palanca-Gil, Victor, Payá-Serrano, Rafael, Quesada Dorador, Aurelio, Morell, Salvador, Ridocci-Soriano, Francisco
Format: article
Publication Date:2014
Country:España
Institution:Universidad Católica de Valencia San Vicente Mártir
Repository:RIUCV. Repositorio de la Universidad Católica de Valencia San Vicente Mártir
Language:English
OAI Identifier:oai:riucv.ucv.es:20.500.12466/6947
Online Access:https://hdl.handle.net/20.500.12466/6947
Access Level:Open access
Keyword:Cardiac resynchronization therapy
Implantable cardioverter defibrillator
Mild systolic dysfunction
Cardiac magnetic resonance
Late gadolinium enhancement
Terapia de resincronización cardiaca
Desfibrilador automático implantable
Disfunción moderada
Resonancia magnética cardiaca
Realce tardío de gadolinio
32 Ciencias Médicas
Description
Summary:Cardiac resynchronization therapy with a defibrillator prolongs survival and improves quality of life in advanced heart failure. Traditionally, patients with ejection fraction > 35 estimated by echocardiography have been excluded. We assessed the prognostic impact of this therapy in a group of patients with severely depressed systolic function as assessed by echocardiography but with an ejection fraction > 35% as assessed by cardiac magnetic resonance.

Similar Items